Other News

Aziyo Completes Enrollment in Prospective Post Market Study of CanGaroo ECM Envelope

SILVER SPRING, Md.–(BUSINESS WIRE)–Aziyo Biologics, Inc. a fully integrated regenerative medicine company, today announced completion of patient enrollment in SECURE, a prospective post market study of 1,000 patients treated with CanGaroo® ECM® Envelope in conjunction with cardiac implantable electronic device (CIED) placement. The CanGaroo ECM Envelope is intended to securely hold a […]

Abiomed Announces Resignation of Chief Financial Officer and Welcomes Back Former Chief Financial Officer as Consultant

DANVERS, Mass., Aug. 28, 2017 (GLOBE NEWSWIRE) — Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support and recovery technologies, announced today that it has accepted the resignation of its Chief Financial Officer, Michael Tomsicek, effective August 24, 2017.  After two years, Mr. Tomsicek is leaving the Company to pursue other […]

Resonetics Acquires Aduro Laser, Adds Disruptive Manufacturing Capability for Laser Cut Tubing

NASHUA, N.H., Aug. 28, 2017 /PRNewswire/ — Resonetics announced today its acquisition of Aduro Laser, an emerging leader in laser processing of tubular components for the medical device industry. In just four years, Aduro has established an innovative business model and proprietary technology to shorten lead times dramatically, enabling customers to iterate rapidly and […]

Medtronic Plans for Renal Denervation Pivotal Trial After New Study Shows Significant Blood Pressure Reductions

Published Simultaneously in The Lancet, the Late-Breaking SPYRAL HTN-OFF MED Study at ESC Successfully Isolates RDN Treatment Effect to Show Compelling Efficacy and Safety of Hypertension Procedure DUBLIN and BARCELONA – August 28, 2017 – Medtronic plc (NYSE:MDT) today announced its intent to move forward with a new renal denervation pivotal trial […]

Abbott (ABT) Introduces Heartmate 3 Left Ventricular Assist System – The Latest Milestone In Therapy For Advanced Heart Failure Patients

ABBOTT PARK, Ill., Aug. 28, 2017 /PRNewswire/ — Abbott (NYSE: ABT) announced today it has received U.S. Food and Drug Administration (FDA) approval for its Full MagLev HeartMate 3 Left Ventricular Assist System (also known as an LVAD). The HeartMate 3 system provides a new option for physicians managing advanced heart failure patients in need […]

C. R. Bard, Inc. (BCR) Snags FDA Premarket Approval of The Lutonix 035 Drug Coated Balloon As The First And Only DCB

C. R. Bard Receives Fda Premarket Approval Of The Lutonix® 035 Drug Coated Balloon As The First And Only Dcb For The Treatment Of Patients With Dysfunctional Av Fistulae New Option to Preserve Vascular Access and Help Hemodialysis Patients Extend Time Between Reinterventions MURRAY HILL, N.J.–(BUSINESS WIRE)–C. R. Bard, Inc. […]

Access Vascular Secures $3.7 Million In Financing

BEDFORD, Mass., Aug. 28, 2017 /PRNewswire/ — Access Vascular, a medical device company developing innovative venous access devices that eliminate thrombotic risk, today announced $3.7 million in funding from individual investors and angelMD, an investment platform and marketplace connecting innovative medical startups, physicians, investors and industry partners. This financing will help support submission of […]

Boehringer Ingelheim Release: Pradaxa (Dabigatran Etexilate) Dual Therapy Showed Lower Rates Of Major Bleeding Versus Triple Therapy With Warfarin In Atrial Fibrillation Patients Undergoing Stent Placement

RE-DUAL PCI™ showed large reductions in the incidence of bleeding complications if Pradaxa® dual therapy was used instead of warfarin triple therapy. Both Pradaxa® doses tested in RE-DUAL PCI™ have been approved for stroke prevention in atrial fibrillation. Data were presented as a late-breaker at the ESC Congress 20171 and published in the […]